PedAM
Pediatric Disease Annotations & Medicines
| Disease | mental depression |
| Phenotype | C0030567|parkinson disease |
| Sentences | 21 |
| PubMedID- 22228826 | depression in parkinson disease (pd) is associated with faster disease progression, lower activities of daily living, and more severe cognitive impairment. |
| PubMedID- 23900322 | Conclusions: motor alterations, cognitive impairment and most importantly depression of patients with parkinson disease are deteminants of burden for their caregivers. |
| PubMedID- 20722714 | Risk of incident depression in patients with parkinson disease in the uk. |
| PubMedID- 26047635 | A pilot study of a cognitive-behavioral treatment for anxiety and depression in patients with parkinson disease. |
| PubMedID- 26209930 | The objective of this meta-analysis was to evaluate the effects of repetitive transcranial magnetic stimulation (rtms) for the treatment of depression in patients with parkinson disease in order to arrive at qualitative and quantitative conclusions about the efficacy of rtms. |
| PubMedID- 24404185 | Nc: normal control, pdd: parkinson disease patients with depression, nd-pd: non-depressed parkinson’s disease patients, na: not applicable, ★: one-way analysis of variance (anova), ▴: two sample t-test, •: pearson x2 test. |
| PubMedID- 26284815 | Objective: depression in parkinson disease (pd) is a common problem that worsens quality of life and causes disability. |
| PubMedID- 22228827 | Background: although face-to-face cognitive-behavioral therapy (cbt) was found to be beneficial for the treatment of depression in parkinson disease (dpd) in a recent randomized-controlled trial, access to care was identified as a critical issue that needs to be addressed in order to improve the management of this nonmotor complication in pd. |
| PubMedID- 22198405 | depression in parkinson disease--epidemiology, mechanisms and management. |
| PubMedID- 25529799 | Increased risk of depression in patients with parkinson disease: a nationwide cohort study. |
| PubMedID- 20042544 | Occurrence risk and structure of depression in parkinson disease with and without dementia: results from the gepad study. |
| PubMedID- 26107935 | Background: to evaluate the risk of premotor symptoms, namely rapid eye movement behavior disorder (rbd), constipation, and depression among patients with newly diagnosed parkinson disease (pd). |
| PubMedID- 21098407 | Background: depression associated with parkinson disease (pd) has a different symptom profile to endogenous depression. |
| PubMedID- 22859701 | Components of depression in parkinson disease. |
| PubMedID- 24800716 | Disexecutive functions and depression in patients with parkinson disease: the impact on rehabilitation outcome. |
| PubMedID- 23138696 | Association of tef polymorphism with depression in parkinson disease. |
| PubMedID- 20686125 | Objective: to investigate, using mri and voxel-based morphometry (vbm), whether specific patterns of gray matter (gm) and white matter (wm) loss are associated with depression in patients with parkinson disease (pd). |
| PubMedID- 23946309 | Objective: to construct a model for depression in parkinson disease (pd) and to study the relative contribution of pd-specific and nonspecific risk factors to this model. |
| PubMedID- 20015839 | Apathy and depression in parkinson disease. |
| PubMedID- 23418798 | Fatigue, sleep disturbances, dementia, and depression are common in patients with parkinson disease. |
| PubMedID- 22857990 | depression is frequently associated with parkinson disease (pd) but neural basis is still unclear. |
Page: 1